These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 1701526)
1. Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age. MacDonald ML; Wagner RM; Slotnick RN Obstet Gynecol; 1991 Jan; 77(1):63-8. PubMed ID: 1701526 [TBL] [Abstract][Full Text] [Related]
2. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967 [TBL] [Abstract][Full Text] [Related]
3. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study. Phillips OP; Elias S; Shulman LP; Andersen RN; Morgan CD; Simpson JL Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome. Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896 [TBL] [Abstract][Full Text] [Related]
5. Fetal gender impact on multiple-marker screening results. Bazzett LB; Yaron Y; O'Brien JE; Critchfield G; Kramer RL; Ayoub M; Johnson MP; Evans MI Am J Med Genet; 1998 Apr; 76(5):369-71. PubMed ID: 9556293 [TBL] [Abstract][Full Text] [Related]
6. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852 [TBL] [Abstract][Full Text] [Related]
7. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies. Benn PA Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476 [TBL] [Abstract][Full Text] [Related]
8. Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening. Palomaki GE; Knight GJ; Haddow JE; Canick JA; Wald NJ; Kennard A Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):675-8. PubMed ID: 7682315 [TBL] [Abstract][Full Text] [Related]
9. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome. Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623 [TBL] [Abstract][Full Text] [Related]
10. Effect of gravidity on maternal serum markers for Down's syndrome. Barkai G; Goldman B; Ries L; Chaki R; Cuckle H Prenat Diagn; 1996 Apr; 16(4):319-22. PubMed ID: 8734805 [TBL] [Abstract][Full Text] [Related]
11. Serum markers for Down's syndrome in relation to number of previous births and maternal age. Wald NJ; Watt HC Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278 [TBL] [Abstract][Full Text] [Related]
12. Maternal serum superoxide dismutase (SOD): a possible marker for screening Down syndrome affected pregnancies. Ognibene A; Ciuti R; Tozzi P; Messeri G Prenat Diagn; 1999 Nov; 19(11):1058-60. PubMed ID: 10589060 [TBL] [Abstract][Full Text] [Related]
13. First- and second-trimester screening: detection of aneuploidies other than Down syndrome. Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME; Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613 [TBL] [Abstract][Full Text] [Related]
14. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies. Rice JD; McIntosh SF; Halstead AC Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658 [TBL] [Abstract][Full Text] [Related]
16. [Prenatal maternal blood screening for the detection of fetal chromosomal abnormalities: clinical importance of the rate of false positives]. Alvarez-Nava F; Soto M; Padrón T; Morales A; Villalobos D; Rojas de Atencio A; Prieto M; Martínez MC Invest Clin; 2003 Sep; 44(3):195-207. PubMed ID: 14552058 [TBL] [Abstract][Full Text] [Related]
17. Combined ultrasound biometry, serum markers and age for Down syndrome risk estimation. Bahado-Singh RO; Oz AU; Gomez K; Hunter D; Copel J; Baumgarten A; Mahoney MJ Ultrasound Obstet Gynecol; 2000 Mar; 15(3):199-204. PubMed ID: 10846774 [TBL] [Abstract][Full Text] [Related]